News

Learn more about the latest news, insights, and events from Delavau Pharmaceutical Partners.

pills3

Continuous Manufacturing Panel Features Delavau General Manager Jay Jones

NEW YORK – March 9, 2017 – Delavau Pharmaceutical Partners General Manager Jay Jones is speaking on behalf of the company as a part of INTERPHEX Live’s “Continuous Manufacturing Opportunities Keep Expanding in Pharma” panel in New York City on March 22. An alternative to traditional batch manufacturing, the continuous manufacturing process minimizes the handling of materials and product. In turn, the potential for human error is reduced and tablet size and weight consistency is increased. Continuous manufacturing is widely recognized as the future of the VMS and OTC industry. “Most contract manufacturers are only in the research phase...

machine

Delavau General Manager Jay Jones Featured on Engineering Convention Panel

ATLANTA, GEORGIA – September 19, 2016 – An expert with more than 30 years of experience in pharmaceutical operations management, Jay Jones, General Manager of Delavau Pharmaceutical Partners was a featured panelist on Continuous Manufacturing and Product Development at the International Society for Pharmaceutical Engineering 2016 annual meeting. Widely recognized as the future of the VMS and OTC industry, continuous manufacturing incorporates quality control directly into the process design. The process minimizes handling of materials and product, which reduces the potential for human error and increases consistency of tablet size and weight. As a result, tablets delivered through Delavau’s...

Fill in to Download

Close Window